NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products
Natco Pharma Ltd Q2FY25; 83% rise in Profits
Categories
Pharmaceutical
Alkem Laboratories Ltd Q2FY25; 14% rise in Profits
Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical
Alembic Pharmaceuticals Ltd Q2FY25; 12% rise in Profits
Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. The company
Abbott India Ltd Q2FY25; 43% fall in Profits
Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within
Glaxosmithkline Pharmaceuticals Ltd Q2FY25; 16% rise in Profits
GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people. Financial Results: Glaxosmithkline Pharmaceuticals Ltd
Ajanta Pharma Ltd Q2FY25; 11% rise in Profits
Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70).
Jubilant Pharmova Ltd Q2FY25; 65% rise in Profits
Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary
Glenmark Pharmaceuticals Ltd Q2FY25; 13% rise in Profits
Glenmark Pharmaceuticals Ltd is a global research-led pharmaceutical company with presence across generics, Specialty and OTC business with operations in over 80
Sun Pharmaceuticals Industries Ltd Q2FY25; 28% rise in Profits
Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations
Hikal Ltd Q1FY25; 26% fall in Profits
Hikal is a partner to companies in the Pharmaceuticals, Crop Protection, and Specialty Chemicals industry. The company is in the business of
Aarti Drugs Ltd Q1FY25; 32% fall in Profits
Established in the year 1984 and a part of $1000 million Aarti Group of Industries, Aarti Drugs Ltd. (ADL) is engaged into
Ipca Laboratories Ltd Q1FY25; 21% rise in Profits
Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals. Financial Results: Ipca Laboratories Ltd reported Revenues for Q1FY25 of ₹2,093.00
Divis Laboratories Ltd Q1FY25; 21% rise in Profits
Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divis Laboratories Ltd reported Revenues for
Wanbury Faces Revenue Decline in Q1FY25 Amid Operational Challenges, Sets Stage for Recovery
Company Overview: Wanbury Ltd., established in 1988, is a prominent player in the pharmaceutical industry. The company has a strong presence in
Wanbury Ltd Q4FY24; 3197% rise in Profits
Incorporated in 1988, Wanbury Ltd is in the business of pharmaceutical and related activities, including research Financial Results: Wanbury Ltd reported Revenues
Wanbury Ltd Q1FY25; 78% fall in Profits
Incorporated in 1988, Wanbury Ltd is in the business of pharmaceutical and related activities, including research Financial Results: Wanbury Ltd reported Revenues
Biocon Ltd Q1FY25; 479% rise in Profits
Biocon is engaged in the business of manufacture of biotechnology products and research services. Financial Results: Biocon Ltd reported Revenues for Q1FY25
Alkem Laboratories Ltd Q1FY25; 91% rise in Profits
Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical
Glenmark Pharmaceuticals Ltd Q1FY25; 97% rise in Profits
Glenmark Pharmaceuticals Ltd is a global research-led pharmaceutical company with presence across generics, Specialty and OTC business with operations in over 80
Aurobindo Pharma Ltd Q1FY25; 61% rise in Profits
Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. Financial Results: Aurobindo Pharma
Gland Pharma Ltd Q1FY25; 26% fall in Profits
Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral